World Patient Safety Day 2025

This World Patient Safety Day, we’re shining a light on how healthcare professionals can build safety into every interaction.

ICH E6 (R3) and Risk-Based Quality Management

This webinar unpacked the major shifts in ICH E6 (R3), showing how teams can embrace RBQM.

ICH E6 (R3) Is Here, But Only 19% Are Ready

ICH E6 (R3) is here, but only 19% of the industry is ready. While awareness is high, meaningful action is lagging.

Powering a Risk-Based Approach to Clinical Trials

TRI is proud to join the Veeva R&D Summit as a Product Partner, showcasing our collaboration.

5 Mistakes That Could Compromise Your Clinical Trial

Explore five common mistakes that can derail your clinical trial and how OPRA helps teams manage risk.

Modernizing Central Monitoring in Clinical Trials

Discover how TRI is transforming clinical research through smarter, data-driven solutions.

Driving Smarter Clinical Trials with RBQM

RBQM is redefining how clinical trials are designed, enabling smarter, more resilient research.

Collaborating Under ICH E6 (R3)

Explore how sponsors and CROs must rethink collaboration and embed quality into every layer of trial execution.

Why ICH E6 R3 Matters for Clinical Trials

Explore how E6 (R3) reshapes trial design, oversight, and culture, and why the industry must be ready to respond.

What is ICH E6 (R3)?

ICH E6 (R3) sets a new global benchmark for Good Clinical Practice, modernizing oversight with principle-based, risk-driven, and digitally enabled trial design.